Captrust Financial Advisors Nuvasive Inc Transaction History

Captrust Financial Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$46.84 - $59.75 $11,241 - $14,340	-240 Reduced 9.45%	2,299 $113,000
Q2 2022 Aug 16, 2022	BUY	$46.84 - $59.75 $20,188 - $25,752	431 Added 20.45%	2,539 $125,000
Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $46,791 - $56,229	973 Added 85.73%	2,108 $120,000
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $1,038 - $1,378	22 Added 1.98%	1,135 $60,000
Q3 2021 Nov 16, 2021	BUY	$56.91 - $67.81 $2,333 - $2,780	41 Added 3.82%	1,113 $67,000
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $2,112 - $2,366	33 Added 3.18%	1,072 $73,000
Q1 2021 May 17, 2021	BUY	$53.26 - $68.08 $50,011 - $63,927	939 Added 939.0%	1,039 $68,000
Q3 2020 Nov 17, 2020	BUY	$47.43 - $60.75 $4,743 - $6,075	100 New	100 $5,000
Q4 2018 Feb 13, 2019	SELL	$47.64 - $71.26 $38,350 - $57,364	-805 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$52.03 - $71.41 $1,352 - $1,856	-26 Reduced 3.13%	805 $57,000
Q2 2018 Aug 13, 2018	BUY	$48.15 - $56.68 $7,415 - $8,728	154 Added 22.75%	831 $43,000
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $7,917 - $10,540	-172 Reduced 20.26%	677 $36,000
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $42,942 - $51,610	849	849 $50,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.